Clinical Trial to Compare the Safety and Pharmacokinetics of YH22162 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 5, 2018

Primary Completion Date

December 8, 2018

Study Completion Date

December 22, 2018

Conditions

Hypertension

Interventions

DRUG

Telmisartan 80mg + Amlodipine 5mg + Chlorthalidone 25mg

White colored oval three-layer tablet

DRUG

Telmisartan 80mg + Amlodipine 5mg + Chlorthalidone 25mg

White and pink colored oval two-layer tablet

Trial Locations (1)

Chonbuk National University Hospital, Jeonju

All Listed Sponsors

lead

Yuhan Corporation

INDUSTRY

NCT03662620 - Clinical Trial to Compare the Safety and Pharmacokinetics of YH22162 in Healthy Volunteers | Biotech Hunter | Biotech Hunter